Literature DB >> 31688242

Small airway disease in chronic obstructive pulmonary disease: insights and implications for the clinician.

Dave Singh1,2, Gabriella Long2, José E D Cançado3, Andrew Higham1.   

Abstract

PURPOSE OF REVIEW: Small airway disease (SAD) is a common feature in chronic obstructive pulmonary disease (COPD) patients. Chronic exposure to cigarette smoking causes inflammation, damage, tissue remodelling and eventually airway loss. These features lead to airflow limitation and defective alveolar ventilation. The aim of this review is to provide clinicians with an up-to-date perspective of SAD in COPD. RECENT
FINDINGS: In this review, we will discuss the key pathological features of SAD. We also review state-of-the-art techniques for measuring SAD, including impulse oscillometry and lung imaging methods. We discuss emerging concepts such as SAD in the earlier stages of COPD and the relationship between SAD and emphysema.
SUMMARY: The current review highlights the importance of targeting small airways early in the course of COPD to tackle disease progression.

Entities:  

Mesh:

Year:  2020        PMID: 31688242     DOI: 10.1097/MCP.0000000000000637

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  6 in total

1.  Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS Cohort.

Authors:  Nathan Yee; Daniela Markovic; Russell G Buhr; Spyridon Fortis; Mehrdad Arjomandi; David Couper; Wayne H Anderson; Robert Paine; Prescott G Woodruff; Meilan K Han; Fernando J Martinez; R Graham Barr; James M Wells; Victor E Ortega; Eric A Hoffman; Victor Kim; M Bradley Drummond; Russell P Bowler; Jeffrey L Curtis; Christopher B Cooper; Donald P Tashkin; Igor Z Barjaktarevic
Journal:  Chest       Date:  2021-11-10       Impact factor: 10.262

2.  The TRIFLOW study: a randomised, cross-over study evaluating the effects of extrafine beclometasone/formoterol/glycopyrronium on gas trapping in COPD.

Authors:  James Dean; Catalina Panainte; Naimat Khan; Dave Singh
Journal:  Respir Res       Date:  2020-12-09

3.  Dysregulation of the CD163-Haptoglobin Axis in the Airways of COPD Patients.

Authors:  Andrew Higham; James M Baker; Natalie Jackson; Rajesh Shah; Simon Lea; Dave Singh
Journal:  Cells       Date:  2021-12-21       Impact factor: 6.600

4.  Forced Oscillation Measurements in Patients with Idiopathic Interstitial Pneumonia Subjected to Pulmonary Rehabilitation.

Authors:  Sabina Kostorz-Nosal; Dariusz Jastrzębski; Piotr Kubicki; Dagmara Galle; Alicja Gałeczka-Turkiewicz; Beata Toczylowska; Dariusz Ziora
Journal:  J Clin Med       Date:  2022-06-24       Impact factor: 4.964

Review 5.  Chronic obstructive pulmonary disease and COVID-19: interrelationships.

Authors:  Dave Singh; Alexander G Mathioudakis; Andrew Higham
Journal:  Curr Opin Pulm Med       Date:  2022-03-01       Impact factor: 3.155

6.  Dexamethasone and p38 MAPK inhibition of cytokine production from human lung fibroblasts.

Authors:  Andrew Higham; Dave Singh
Journal:  Fundam Clin Pharmacol       Date:  2020-11-14       Impact factor: 2.748

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.